Kerry Costello

Kerry Costello has extensive experience in the pharmaceutical industry. Kerry is currently the Vice President, Apitegromab Program Lead at Scholar Rock, where they lead a team focused on developing a novel anti-myostatin agent for the treatment of Spinal Muscular Atrophy. Prior to this role, Kerry was the Senior Director of Commercial Development at Scholar Rock, responsible for providing strategic direction and leadership for all products in the neuromuscular disorders, oncology, and anemia/blood disorders therapeutic areas.

Before joining Scholar Rock, Kerry ran their own consulting firm, Kerry Costello Consulting, LLC, for two years, where they served as the Principal, providing strategic guidance to companies in the pharmaceutical industry.

Earlier in their career, Kerry worked at Vertex Pharmaceuticals for over 20 years. During their time there, they held various roles, including Director of Global Brand Lead for ORKAMBI, a therapy for Cystic Fibrosis, and Associate Director of Marketing for KALYDECO. Kerry also served as the Senior Marketing Manager for New Product Planning and Strategy, Manager of Global Market Research, Program Planner in Program Management and Strategic Planning, and Clinical Administrator.

Kerry's career in the pharmaceutical industry began at Brigham and Women's Hospital, where they worked as a Clinical Research Coordinator.

Kerry Costello completed a Master of Business Administration (MBA) degree in Business from Boston College Carroll School of Management from 1998 to 2001. Earlier, Kerry pursued a Bachelor's Degree in Clinical Laboratory Science/Medical Technology/Technologist from the University of Massachusetts, completing it from 1989 to 1993.